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Identification of transcriptional networks responding to pyrroloquinoline
quinone dietary supplementation and their influence on thioredoxin
expression, and the JAK/STAT and MAPK pathways
Eskouhie TCHAPARIAN*†1, Lisa MARSHAL†, Gene CUTLER†, Kathryn BAUERLY*, Winyoo CHOWANADISAI*, Michael SATRE*,
Calliandra HARRIS* and Robert B. RUCKER*1
*Department of Nutrition, One Shields Avenue, University of California Davis, Davis, CA 95616, U.S.A., and †Amgen, 120 Veterans Blvd, San Francisco, CA 94080, U.S.A.
PQQ (pyrroloquinoline quinone) improves energy utilization and
reproductive performance when added to rodent diets devoid of
PQQ. In the present paper we describe changes in gene expression
patterns and transcriptional networks that respond to dietary
PQQ restriction or pharmacological administration. Rats were
fed diets either deficient in PQQ (PQQ−) or supplemented with
PQQ (approx. 6 nmol of PQQ/g of food; PQQ+). In addition,
groups of rats were either repleted by administering PQQ to
PQQ− rats (1.5 mg of PQQ intraperitoneal/kg of body weight
at 12 h intervals for 36 h; PQQ−/+) or partially depleted by
feeding the PQQ− diet to PQQ+ rats for 48 h (PQQ+/−). RNA
extracted from liver and a Codelink® UniSet Rat I Bioarray
system were used to assess gene transcript expression. Of
the approx. 10000 rat sequences and control probes analysed,
238 were altered at the P < 0.01 level by feeding on the
PQQ− diet for 10 weeks. Short-term PQQ depletion resulted in
changes in 438 transcripts (P < 0.01). PQQ repletion reversed
the changes in transcript expression caused by PQQ deficiency
and resulted in an alteration of 847 of the total transcripts
examined (P < 0.01). Genes important for cellular stress (e.g.
thioredoxin), mitochondriogenesis, cell signalling [JAK (Janus
kinase)/STAT (signal transducer and activator of transcription)
and MAPK (mitogen-activated protein kinase) pathways] and
transport were most affected. qRT-PCR (quantitative real-time
PCR) and functional assays aided in validating such processes as
principal targets. Collectively, the results provide a mechanistic
basis for previous functional observations associated with PQQ
deficiency or PQQ administered in pharmacological amounts.
Key words: gene microarray, Janus kinase/signal transducer
and activator of transcription signalling pathway (JAK/STAT
signalling pathway), mitogen-activated protein kinase signalling
pathway (MAPK signalling pathway), mitochondrion, oxidative
metabolism, pyrroloquinoline quinone (PQQ).
INTRODUCTION
A number of physiological properties have been attributed
to PQQ (pyrroloquinoline quinone) ranging from classical
vitamin/cofactor functions to those important for anti- and pro-
oxidant potential, protection of neuronal cells and tissues, and
mitochondriogenesis [1–14]. Although a role as a vitamin in
animal or human nutrition is unlikely [15–17], similar to other
polyphenolic biofactors, PQQ does interact in pathways important
for cell signalling [18–21].
When PQQ is omitted from chemically defined diets fed
to mice and rats, a wide range of systematic responses are
observed including growth impairment, compromised immune
responsiveness and abnormal reproductive performance [1–4].
Varying PQQ in highly refined diets also causes modulation in
hepatic mitochondrial content and alteration in mitochondrial-
related amino acid and lipid metabolism [1,2,20,21]. We have
recently provided evidence that changes in mitochondrial amount
were associated with modulation in CREB (cAMP-response-
element-binding protein) phosphorylation and subsequent PGC-
1α (peroxisome-proliferator-activated receptorγ co-activator-1α)
directed up-regulation of NRF-1 (nuclear respiratory factor-1),
NRF-2 and Tfam (transcription factor A, mitochondrial) mRNA
expression [20].
Both PQQ and its principal derivative [the PQQ amino acid
adduct IPQ (imidazolopyrroloquinoline)] are widely distributed
in animal and plant tissues and fluids ranging from pico- to nano-
molar concentrations [21–25]. Given that the systemic effects
of PQQ deprivation are influenced at levels of dietary intake in
the nanomolar to micromolar range, in the present study purified
diets were used to reduce the effects of other bioactive factors and
xenobiotics, such as those found in typical rodent chow diets [26].
Furthermore, it is known that Escherichia coli and other organisms
commonly found in intestinal microflora do not synthesize PQQ
[27–29]. As a consequence, we infer that PQQ in mammals is
derived at least in part from dietary or food sources. Accordingly,
dietary conditions were also chosen to assess responses to short-
and longer-term PQQ deprivation. Gene expression microarray
Abbreviations used: AMPK, AMP-activated protein kinase; ASD, amino-acid-semi-purified-based diet; CF, cystic fibrosis gene; CREB, cAMP-response-
element-binding protein; ERK, extracellular-signal-regulated kinase; FDR, false discovery rate; GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
GDH, glucose dehydrogenase; HMG-CoA, 3-hydroxy-3-methylglutaryl-CoA; IPA, ingenuity pathways analysis; IPQ, imidazolopyrroloquinoline; JAK, Janus
kinase; LC, laboratory chow; MAPK, mitogen-activated protein kinase; MAPKKK, MAPK kinase kinase; mtDNA, mitochondrial DNA; ND-5, nicotinamide
adenine dinucleotide dehydrogenase-5; NPY, neuropeptide Y; NRF, nuclear respiratory factor; PGC-1α; peroxisome-proliferator-activated receptor γ co-
activator-1α; PQQ, pyrroloquinoline quinone; qRT-PCR, quantitative real-time PCR; SAM, significance analysis of microarrays; STAT, signal transducer and
activator of transcription; Tfam, transcription factor A, mitochondrial.
1 Correspondence may be addressed to either of these authors (email eskouhie@amgen.com or rbrucker@ucdavis.edu).
The raw microarray data from the present study are available from the NCBI (National Center for Biotechnology Information) GEO (Gene Expression
Omnibus) database (http://www.ncbi.nlm.nih.gov/geo) under accession number GSE17811, and are also available with the Supplementary data for this
article at http://www.BiochemJ.org/bj/429/bj4290515add.htm.
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profiling was used as a comprehensive approach to determine
whether changes in PQQ dietary protocols or pattern of exposure
significantly modulate the expression of specific transcription
networks.
EXPERIMENTAL
Reagents
Chemicals and reagents used in diets and assays were obtained
from Fisher Chemicals, Sigma–Aldrich, Fluka or Supelco
and were of the highest purity available. Amino acids for
diet preparations were purchased from Ajinomoto. Reverse
transcription and PCR enzymes and reagents were purchased
from Applied Biosystems or Ambion. Microarray reagents and
kits (Codelink® Rat Whole Genome Bioarray System) and
supporting Codelink® statistical software were obtained from
Applied Microarrays. RNA extraction and purification kits were
purchased from Qiagen. PQQ was a gift from Mitsubishi Gas
Chemical Company.
Animal studies, diets and husbandry protocols
Rats were used and housed individually in plastic cages. Recycled
fibre, devoid of inks or dyes, was used for bedding (Carefresh Total
1 Clean Bedding). Animals were provided free access to food and
water. The water supply was filtered through an activated carbon
cartridge (Carbon Capsule 12122; Gellman Sciences), and then
filtered through a 0.2 mm bacterial filter (Mini Capsule 12122;
Gellman Sciences). Food cups and cages were changed twice
weekly. Rats were housed and maintained in an Association
for Assessment and Accreditation of Laboratory Animal Care
International approved facility with approval from the campus
Institutional Animal Care and Use Committee. Rats were fed on
an ASD (amino-acid-semi-purified-based diet), which provided
all known required nutrients in sufficient quantities to provide
maximal growth, reproduction and lactation [1–4]. The ASD
contained <5 fmol of PQQ/g.
The effects of PQQ depletion and repletion were examined
using male rat pups derived from Sprague–Dawley dams fed
on the basal ASD. To produce PQQ deficiency, 10-week-old
virgin Sprague–Dawley rats were mated and, during the last
10 days of gestation, two-thirds of the rats were fed the basal
ASD (PQQ−), while the remaining one-third were fed a PQQ-
supplemented diet (2 mg of PQQ/kg of food or approx. 6 nmol/g
of food; PQQ+). Offspring were then assigned to and fed the
same diets as their corresponding dams (n = 6). At 6.5 weeks
post-weaning, half of the PQQ− and PQQ+ rats were divided to
generate short-term repleted (PQQ−/+) and depleted (PQQ+/−)
groups. The repletion was accomplished by administering PQQ
by intraperitoneal injection at 1.5 mg of PQQ/kg of body weight
every 12 h for a period of 36 h. Short-term depletion was achieved
by switching PQQ+ rats to the PQQ− diet for 48 h. On the basis of
previous observations [28,29], the depletion study was conducted
for 48 h to allow a washout period for presumed cellular reserves
of PQQ. An additional group of rats (n = 6) fed a standard LC
(laboratory chow) diet was used as a reference.
Microarray analysis and statistics
Total RNA was isolated from the liver of each rat using TRIzol®
reagent (Invitrogen) and further purified using Qiagen RNA
mini-kits. On-column DNA digestion was performed using an
RNase-free DNase kit (Qiagen) to remove DNA residues. To
ensure the RNA quality of each sample, integrity and purity
were assessed by use of the Agilent Bioanalyser. The biotin-
labelled cRNA target was prepared by a linear amplification
method using a Codelink® expression array kit (GE Lifesciences).
Total RNA (10 μg per sample) was used for cDNA synthesis
using DNA oligonucleotides and T7 RNA polymerase. A set of
bacterial mRNA controls was also included for the synthesis.
The first-strand cDNA synthesis was followed by the second
strand synthesis. The resulting DNA served as the template for
an in vitro transcription reaction to produce targeted cRNA. The
in vitro transcription reaction was performed with the addition of
biotinylated nucleotides to label the cRNA. This method produces
an approx. 1000-fold linear amplification of the input poly(A)–
RNA. RNeasy Mini spin columns (Qiagen) were used for cRNA
purification. The quality and yield of cRNA was assessed and
subjected to chemical fragmentation.
The fragmented cRNA samples (10 μg each) were applied
to bioarrays and hybridized overnight (17 h) in a temperature
controlled shaking incubator, washed and followed by
streptavidin–phycoerythrin conjugate staining. A subsequent
series of less stringent washes were also performed to remove
any unbound dye conjugates. Six individual animals per group
were used in the analysis; no samples were pooled.
Codelink® expression analysis software provided automatic
alignment and data extraction. Positive and negative bacterial
controls were added during the target preparation to serve as
overall platform performance controls. The Codelink® software
also provided background correction. A global Loess function was
applied to normalize the microarray data, and to correct for bias
and the high-variance data points [30–32]. The probes for each
experiment were sorted based on the product of their experimental
and reference normalized signal intensities.
Gene expression was assessed by supervised analysis with
the SAM (significance analysis of microarrays) algorithm
using the Integromics Biomarker Discovery for microarray data
analysis software (http://www.integromics.com). SAM is similar
to Student’s t test, but with permutations to calculate the FDR
(false discovery rate) and to pick out genes where the ex-
pression level is significantly different between two groups of
samples [33–35]. Normalized expression values from Codelink®
analysis were used for a two-class unpaired SAM analysis.
The SAM software estimated the false discovery rate and
generated a q-value for each gene. The q-value for each gene
represents the probability that it is falsely called differentially
expressed. Similar to a P-value, a smaller q-value indicates a
more significant differential expression. This is an advantage
over other techniques (e.g. ANOVA followed by a Bonferroni,
Tukey, Newman–Keuls or Dunnett’s post-test), which assume
equal variance and/or independence of given variables. A
5% FDR and an absolute fold-change value of 2.0 were
used criteria to screen for differentially expressed genes and
filter genes between different groups. Additional statistical
data are provided in Supplementary Figures S1 and S2 (at
http://www.BiochemJ.org/bj/429/bj4290515add.htm).
IPA (ingenuity pathways analysis)
An additional analysis using IPA software (http://www.
ingenuity.com/index.html) was performed to identify principal
processes associated with functional categories of genes that
responded to changes in PQQ nutritional status. PQQ data sets
(PQQ−, PQQ+/− or PQQ−/+) with fold changes of >2.0
(relative to the corresponding control groups) and SAM analysis
of q<5.0 were uploaded into the application and each gene was
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Table 1 PQQ status, body weight, liver/body weight ratio, plasma PQQ levels and liver mtDNA/nuclear DNA ratios
PQQ+, values for rats fed on an ASD containing 2 mg/kg PQQ; PQQ−, values for rats fed on an ASD devoid of PQQ; PQQ+/−, values for rats subjected to a short-term PQQ depletion (48 h);
PQQ−/+, values for rats subjected to a PQQ repletion via intraperitoneal injection at 1.5 mg of PQQ/kg of body weight every 12 h for a period of 36 h. The relative amounts of liver mitochondrial
DNA (mtDNA) and nuclear DNA measured by real-time PCR. The targeted genes were the nuclear CF and the mitochondrial ND-5 gene. Values within each row labelled with differing superscript
letters indicate a difference between the groups of P < 0.05 using a Dunnett’s test.
PQQ treatment group
Parameter PQQ+ PQQ− PQQ+/− PQQ−/+ LC
Body weight (g) 220 +− 11a 225 +− 16a 221 +− 13a 231 +− 8a 250 +− 22a
Liver/body weight (% relative to LC values) 96 +− 5a 82 +− 4 b 101 +− 4a 91 +− 4a 100 +− 5a
Plasma PQQ (nM) 12 +− 3a 1.5 +− 2.0b 8 +− 4a 17 +− 7a 4.0 +− 2.0b
Liver mtDNA/nuclear DNA 1.05 +− 0.24a 0.76 +− 0.13b 0.82 +− 0.2a,b 1.3 +− 0.2a 1.1 +− 0.2a
mapped to its corresponding gene object using the Ingenuity
pathways knowledge base. A functional and group comparison
analysis was then performed to identify functional categories that
responded to changes in PQQ status. A Fisher’s exact test was
performed to calculate whether a given biological function was
due to chance. Using the IPA statistical platform, a score of 3
(P < 0.01) was used as the cut-off for identifying gene networks
that were significantly affected by PQQ.
qRT-PCR (quantitative real-time PCR)
Nine genes were chosen to aid in validating the bioarray
results. PCR expression profiles were obtained for carnitine-
O-octanoyltransferase, HMG-CoA (3-hydroxy-3-methylglutaryl-
CoA) lyase, the cytochrome P450 genes CYP4A3 and CYP7A1,
glucokinase, lipocalin 2, monoacylglycerol lipase, Raf1 and
STAT3 (signal transducer and activator of transcription 3) as
markers for MAPK (mitogen-activated protein kinase)-related
signalling, changes in secondary or oxidative metabolism
pathways [36].
Two further genes, the c-fos oncogene and NPY (neuropeptide
Y), were chosen as additional markers [37–39]. These genes
are of relative low abundance and had relatively high FDR
values, but were nevertheless chosen for qRT-PCR, because
changes in expression can often suggest the involvement of
cell signalling associated with MAPK/ERK (extracellular-signal-
regulated kinase) or adipocytokine pathways and/or alteration
in mtDNA (mitochondrial DNA) expression [40,41]. For c-fos
and NPY , total RNA (1 μg from individual samples) containing
the first-strand primer [oligo(dT)] was incubated at 65 ◦C for
5 min and chilled on ice for 2 min. Reverse transcription was
performed in a total volume of 20 μl containing 0.2 mM of each
dNTP, 200 units of MMLV (Moloney-murine-leukaemia virus)
reverse transcriptase and RNAsin at 42 ◦C for 45 min, followed
by 94 ◦C for 5 min. The cDNA obtained was next diluted to a final
concentration of 10 ng/μl and stored at −80 ◦C.
The qRT-PCR analyses [40,41] were processed with an
ABI Prism 7300 sequence detection system (PE Applied
Biosystems). GAPDH (glyceraldehyde-3-phosphate dehydro-
genase) and β-actin mRNA levels were used as references.
Dual-fluorescent non-extendable probes were used and were
labelled with 6-carboxyfluorescein at the 5′-end and with 6-carbo-
xytetramethylrhodamine at the 3′-end in all primers and probe
combinations (25 μl reaction volumes containing 900 nM primers
and 250 nM Taqman® probe) and universal thermal cycling
parameters. Amplification involved incubation at 95 ◦C for 10 min
to activate the Taq polymerase, followed by a two-step PCR
for 40 cycles: denaturation 15 s at 95 ◦C, and annealing and
extension for 1 min at 60 ◦C. Following amplification, levels
of mRNA expression for the selected gene sequences were
normalized relative to either GAPDH or β-actin expression using
the comparative cycle time (Ct) method [41,42]. For the relative
expression of the c-fos oncogene and NPY , GAPDH was used.
Liver mtDNA levels
The relative amounts of liver mtDNA were measured by qRT-
PCR [42–44]. DNA was extracted with phenol/chloroform
and precipitated with ethanol. For nuclear DNA quantification,
10 ng of DNA was used as a template. Rat-specific primers
were selected using the Primer Express® Software (Applied
Biosystems). Primers for nuclear CF (cystic fibrosis) were:
forward 5′-AAACTCAGGATAGCTGTCCGTTTAG-3′ and re-
verse 5′-GCCAAATGATAGCATGGAACTCT-3′. For mtDNA
quantification, 0.1 ng of DNA was used as a template and primers
for mitochondrial ND-5 (nicotinamide adenine dinucleotide
dehydrogenase-5) were: forward 5′-GGATGATGATATGG-
CCTTGCA-3′ and reverse 5′-CGACTCGGTTGTAGAGGAT-
TGC-3′. PCR was performed using an ABI 7900HT real-
time thermocycler (PerkinElmer) coupled with SYBR Green
technology (Applied Biosystems) and the following cycling
parameters: stage 1, 50 ◦C for 2 min; stage 2, 95 ◦C for 10 min;
stage 3, 40 cycles for 95 ◦C for 15 s; 60 ◦C for 1 min; and stage
4, 95 ◦C for 15 s; 95 ◦C for 15 s. The linearity of the dissociation
curve was analysed using the ABI 7900HT software. Each sample
was analysed in duplicate. The mean cycle time of the linear
part of the curve was designated Ct. Relative mitochondrial copy
number to nuclear copy number was assessed by a comparative Ct
method (ΔCt mitochondria/nuclear = Ct mitochondria−Ct nuclear) to assess for
the fold-change for mtDNA/nuclear DNA in liver from PQQ−,
PQQ+, PQQ−/+ and PQQ+/− rats. Values are expressed as
the means +− S.E.M. using a Dunnett’ss test to estimate statistical
significance.
Mitochondrial-related genes
In a separate study, groups of PQQ− and PQQ+ rats were
used to obtain relative Tfam and PGC-1α mRNA levels and
reconfirm relationships related to changes in mtDNA levels.
Livers from individual rats were removed intact, weighed,
examined and rapidly flash-frozen for RNA and DNA extractions.
Blood was also collected in heparinized tubes and immediately
centrifuged. Plasma was obtained following centrifugation and
frozen at −70 ◦C until analyses. For the relative expression
of Tfam and PGC-1α, β-actin was used for normalization.
The targeted PCR Ct value (i.e. the cycle number at which
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Table 2 Metabolic stress, cell signalling and immune function-related genes influenced by changes in PQQ status
An asterisk (*) indicates a significant increase or decrease in gene expression relative to values for the corresponding control group. The analysis was performed by means of SAM analysis using
the Integromics Biomarker Discovery microarray data analysis software. Values within each row labelled with differing superscript letters indicate a difference between the groups of P < 0.05
using a Dunnett’s test. CaM, calmodulin; CDK, cyclin-dependent kinase; CTL, cytotoxic T-cell; IL, interleukin; NF-κβ , nuclear factor κB; NMDA, N-methyl-D-aspartate; PG, prostaglandin; SAPK,
stress-activated protein kinase; TGF, transforming growth factor; TNF, tumour necrosis factor.
PQQ treatment group (fold change relative to PQQ+)
Gene PQQ− PQQ+/− PQQ−/+ Associated functions
Metabolic stress and apoptosis-related genes
UVB radiation-activated UV96 mRNA −5.1*a 1.3b 7.8*c UV radiation-induced cellular stress-associated gene
Integrin-associated protein −4.3*a 1.1b 6.3*c Regulation of NF-κβ
Receptor-interacting serine-threonine kinase 3 −2.1*a 1.0a,b 1.3b Apoptosis, component of the TNF receptor-I signalling complex
Huntingtin-interacting protein −2.1*a −1.6a 5.6*b Associated with apoptosis
BAX −2.0a 1.6b 8.0*c Pro-apoptotic regulator that is involved in a wide variety of cellular
activities (e.g. mitochondrial membrane porosity)
Catechol-O-methyl transferase −1.5a 13.6*b 27.8*c Cellular stress; involved in IL-1 signalling
Smad 5 −1.2a −1.4a 3.2*b Modulation of TGF-β ligands
STAT3 −1.2a −1.2a 7.3*b Transcription acute-phase response factor that is activated by nuclear
co-activator 1
Lyric −1.2a 1.1a 4.1*b Activates the NF-κβ transcription factor
D-site albumin promoter-binding protein 4.8*a −2.7*b −5.9*b Transcription factor; down-regulation is associated with reduced
metabolic stress and apoptosis
p75-like apoptosis-inducing death domain protein 2.7*a −1.2b −3.0*c Apoptosis; is expressed in high amounts in the embryonic tissue and
down-regulated in adult tissue
5-Hydroxytryptamine (serotonin) receptor 1F 1.5a −1.5a −3.6*c Serotonin receptor
Heat-shock factor 2 1.2a 1.2a 2.6*b Stress-related chaperon transport functions
Neuraminidase 2 1.1a −2.9*b −2.4*b Sialidase (cleaves neuraminic acid glycosidic linkages), important to
the mobility of virus and related particles
Prostaglandin D2 synthase 1.0a 1.2a −2.4*b Glutathione-independent prostaglandin D synthase that catalyses the
conversion of PGH2 into PGD2
MAPK and MAPK phosphatases
Receptor-interacting serine/threonine kinase 3 −2.1*a 1.0b 1.3b Component of the TNF receptor-I signaling complex
3-Phosphoinositide-dependent protein kinase-1 −1.6a −1.4a 3.1*b Signalling processes important for development; activates various
MAPK signalling pathways
Dual-specificity phosphatase 7 −1.3a −1.7a 2.1*b Negatively regulate the activity of MAPKs in response to changes in
the cellular environment (e.g. heat or metabolic stress)
MAPKKK12 −1.2 a −1.3a 3.1*b An activator of the JNK/SAPK pathway
Tyrosine protein kinase pp60 −1.1a −1.1a 2.9*b A protein kinase C (Ca2+/phospholipid-dependent); known to
phosphorylate epidermal growth factor receptor and reduce its
affinity for epidermal growth factor
Serine/threonine kinase 3 2.8*a 3.2*a −3.0*b MAPK that is activated in response to cellular stress
MAPK phosphatase 2.0*a 1.0a −2.6*b Up-regulated during stress; modulates MAPK activities that are
sensitive to changes in the cellular environment
Protein tyrosine phosphatase 4a1 1.5a −1.6b −2.8*c Up-regulated during stress; modulates MAPK activity
Cyclin A2 1.3a 1.5a −3.7*b Regulators of CDK kinases important to the temporal co-ordination of
mitotic events
RAS p21 protein activator 1 1.2a −1.2a −4.0*b Cytoplasmic GAP1 family of GTPase-activating proteins important to
cell proliferation; most abundant in embryonic tissue
CaM-kinase II inhibitor α 1.0a −1.4a 3.1*b Serine/threonine protein kinase inhibitor in the Ca2+/CaM-
dependent protein kinase subfamily
MAPK14 1.3a −3.9*b −2.7*b A p38 kinase, activated by cellular stress; MAPK 14 activates ERK
and kinases in Ras-oncogene related pathways
Immune and neural function
Cathepsin H −2.6*a −4.3*b 2.4*c Lysosomal cysteine proteinase
Lysozyme −2.4*a −1.7*a 4.0*b A major component of the innate immune system
CTL target antigen −2.3*a −1.4b 1.8*c Antigen to killer T-cells
Complement component 1 −2.2*a −1.1b 1.3c Important for the complement fixation sites of immunoglobulin
Transcription factor 4 −2.2*a −1.7*a 7.0*b Immune function
STAT5B −2.0*a −1.2a 1.6b T-cell receptor signalling, apoptosis, sexual dimorphism of liver gene
expression
Basigin −1.4a 1.7b 3.8*b Member of the immunoglobulin super family with a number of
functions (e.g. lymphocyte recognition) related to early
development
CD14 antigen −1.7*a −1.1b 1.5b,c Immune response
MHC II, DM β class II −1.7*a −1.1b 2.2*c Immune response
JAK3 1.0a 1.6a 2.3*b Transduces a signal in response to its activation via tyrosine
phosphorylation by interleukin receptors; mutations of JAK3 result
in severe immunodeficiency; mice that do not express JAK3 have
T-cells and B-cells that fail to respond to many cytokines
c© The Authors Journal compilation c© 2010 Biochemical Society© 2010 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
Genes responsive to pyrroloquinoline quinone 519
Table 2 Continued
PQQ treatment group (fold change relative to PQQ+)
Gene PQQ− PQQ+/− PQQ−/+ Associated functions
Presenilin 1 −3.6*a −1.6b 2.4*c Proteinase associated with amyloidal protein defects
RAF-1 −1.6a 1.1a 15.5*b Receptor important for cellular proliferation and regulation by
neuregulins, important for the development of the nervous
system
Ninjurin −1.6a 1.0a 3.1*b Nerve injury-induced protein involved in nerve regeneration
and in their formation
Neuropilin −1.1a 1.2a 5.8*b Semaphorin binding is especially important in neural system
development
Cholinergic receptor, nicotinic, α polypeptide 1 −1.1a −1.6a,b −2.0*b Acetylcholine receptors
Neurotrophin-3 3.6*a 2.2*a 1.1b Protein growth factors important to peripheral and central
nervous system function
Benzodiazepine receptor 2.7*a −1.4b −2.0*b Enhances the effects of the neurotransmitter γ -aminobutyric
acid
Plexin A3 2.0*a −1.1b −5.0*c Interacts with RAC-α serine/threonine protein kinase, a
mediator of growth factor-induced neuronal survival
Glutamate receptor, ionotropic, NMDA2B 1.0a 1.5a −4.7*b NMDA receptor important for synaptic transmissions
Cholinergic receptor, nicotinic, β polypeptide 1 1.4a 1.1a −2.6*b Acetylcholine receptor
emitted fluorescence exceeds 10× the S.D.) of baseline emissions
(measured from cycles 3 to 15) was normalized to the GAPDH or
β-actin PCR Ct values by subtracting these values from their
respective target PCR Ct value to derive a Ct value. From
the Ct value, the relative mRNA expression level for each
targeted transcripts was calculated by relative mRNA expression
{[2−(Ct target−Ct control gene)]×100 (to give a percentage)}. A DNA
positive control was also run for each set of assays. Results
are reported as means +− S.E.M. for each sample in triplicate.
For the PGC-1α and Tfam primer sets, the sequences used
were: PGC-1α, forward 5′-AATGAGCCCGCGAACATATT-3′
and reverse 5′-TGAGGACCGCTAGCAAGTTTG-3′; Tfam ,
forward direction 5′-AACGCCTAAAGAAGAAAGCACAA-3′
and reverse 5′-CCGAGGTCTTTTTGGTTTTCC-3′.
Plasma sphingosine and triglycerides
Plasma sphingosine and triacylglycerols were measured as
indices of functional perturbations in phospholipid and neutral
lipid metabolism. Lipids extracted in the presence of authentic
internal standards by the Folch method with chloroform/methanol
(2:1 v/v). Individual lipid classes were separated by liquid
chromatography. Each lipid class was transesterified in 1% (v/v)
sulfuric acid in methanol under a nitrogen atmosphere at 100 ◦C
for 45 min. The resulting fatty acid methyl esters were extracted
from the mixture with hexane containing 0.05% butylated
hydroxytoluene and prepared for gas chromatography under
nitrogen. Fatty acid methyl esters were separated and quantified
by capillary gas chromatography (Agilent Technologies model
6890) equipped with a 30 m DB-88MS capillary column (Agilent
Technologies) and a flame-ionization detector. The basis for these
assays evolved from the IPA focusing on canonical lipid pathways
that were significantly influenced by changes in PQQ status.
PQQ estimation
A GDH (glucose dehydrogenase)-based assay system was used to
estimate dissociable PQQ levels in plasma as described previously
[1–4,45]. The recovery of PQQ added to assays as an external
spike was >85%.
RESULTS
Animals
PQQ deficiency resulted in a reduction in the relative liver weight
when compared with body weight, an effect that was reversed
upon PQQ repletion. Changes in body weights were not obvious at
week 10 (Table 1, also see the Discussion section). Plasma levels
of PQQ for rats fed the basal diet (ASD), as well as changes
in the relative levels of mtDNA, largely reflected the levels of
dietary PQQ for the rats fed the ASD. Results from rats fed an LC
diet are also shown for comparison. The lower values for ‘free’
PQQ in plasma of rats fed LC may reflect: (i) variable intake;
(ii) differences due to PQQ adduct formation (e.g. IPQ, see
[21]); and/or (iii) a decreased bioavailability of PQQ due to the
complexity and extensive processing of LC diets [29]. The PQQ
content of LC measured over the last 4 years routinely ranges
from 1 to 5 mg of PQQ/kg of diet.
Microarray analysis
Of the transcripts analysed by microarray, 10 weeks of PQQ
deprivation caused a change in 238 transcripts, and short-term
PQQ deficiency (for 48 h) caused a change in 438 transcripts
relative to the PQQ+ group (P < 0.01). When PQQ-deficient
rats were subjected to short-term PQQ repletion, approx. 8.5%
or 847 genes (P < 0.01) were up- or down-regulated relative
to the corresponding PQQ− group. With regard to changes in
PQQ status, among the genes altered were genes associated with
cellular stress, cell signalling or immune and neural function
(Table 2). Changes in relative transcript levels brought about by
PQQ deficiency or short-term depletion consistently responded
to PQQ repletion (PQQ−/+), which resulted in a reversal in the
direction of expression or an amplification in expression. Values
for short-term PQQ deficiency were intermediate between the
PQQ− and PQQ−/+ groups. Moreover, the results presented
in Table 2 are consistent with observations published previously
on the effects of PQQ supplementation and deficiency in animal
models and cells; e.g. we have reported that PQQ-deficient rats
and mice express dyssynchronous changes in development and
immune function [3,4].
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Table 3 Cellular transport, assembly, growth, cell cycling and extracellular matrix formation genes influenced by changes in PQQ status
An asterisk (*) indicates a significant increase or decrease in gene expression relative to values for the corresponding control group. The analysis was performed by means of SAM analysis using
the Integromics Biomarker Discovery microarray data analysis software. Values within each row labelled with differing superscript letters indicate a difference between the groups of P < 0.05 using
a Dunnett’s test. ABC, ATP-binding-cassette; CDK, cyclin-dependent kinase; DMT, divalent metal transporter; ER, endoplasmic reticulum; MARCKS, myristoylated alanine-rich protein C-kinase
substrate; SNAP, soluble N-ethylmaleimide-sensitive fusion protein-attachment protein; VAMP, vesicle-associated membrane protein.
PQQ treatment group (fold change relative to PQQ+)
Gene PQQ− PQQ+/− PQQ−/+ Associated functions
Transport
Solute carrier family 28, member 2 −2.1*a 1.0b 1.0b Sodium-coupled nucleoside transporter
Solute carrier family 34, member 2 −2.0*a 2.2*b 4.2*c Sodium-dependent phosphate transport
Transporter 1, ATP-binding cassette, subfamily B −2.8*a 1.3b 2.3*c Member of the ABC transport family; cholesterol efflux regulatory
protein
Embigin 5 −2.0*a 1.2a 1.5b Monocarboxylate transporter
DMT1-associated protein −1.2a −1.1a 2.1*b Divalent metal ion (e.g. Fe2+) transporter
Aquaporin 8 −2.2*a 1.0b 3.6*c Water transport; localized in the inner mitochondrial membrane
Solute carrier family 2, member 13 1.3a 1.1a −3.3*b Member of the facilitated glucose transporter family
Solute carrier family 4, member 4 1.0a −1.1a 3.4*b Electrogenic sodium bicarbonate co-transporter
Solute carrier family 4, member 1 1.6a −2.2*b −4.0*c Chloride-bicarbonate cotransporter
Solute carrier family 6 1.3a 1.0a −2.7*b Co-transport of Na+ and Cl− and neurotransmitter molecules (family
includes carriers for γ -aminobutyric acid,
noradrenaline/adrenaline, dopamine, serotonin, proline, glycine,
choline, betaine and taurine)
Solute carrier family 14, member 2 1.2a −5.6*b −1.2a Urea transporter
Solute carrier family 17 1.2a 1.0a 6.5*b Phosphate transporter
Solute carrier family 18 2.3*a −1.6b −6.8*c Vesicular monoamine transporter
Solute carrier family 20, member 1 1.7*a −1.1a −3.0*c Phosphate transporter
Similar to solute carrier family 2, member 5 2.4*a 2.5*a −1.4b Integral membrane transporter, similar to those in the facilitated
glucose transporter family
Similar to solute carrier 37 1.2a −1.3a −2.0*b Glycerol 3-phosphate transporter
Cellular assembly
Epimorphin −2.5*a 1.1b 2.3b Intracellular vesicle docking
MARCKS-like protein −1.9*a 1.0b 1.0b Interacts with dynactin, ER-to-Golgi transport
Signal transducer and activator of transcription 5B −2.0*a −1.2a 1.6b Activation of tethering signalling components, apoptosis
Epimorphin −1.2a 1.3a 2.3*b Intracellular vesicle docking protein
Golgi SNAP protein, member 2 −1.2a −1.9a 5.4*b Trafficking of membrane proteins that travel among the medial- and
trans-Golgi compartment
GTPase Rab8b −2.3*a −2.0*a 2.9*b Rab GTPases regulate many steps of membrane trafficking: vesicle
formation, vesicle movement along actin and tubulin networks,
and membrane fusion
Transgelin −1.6a −1.0a 3.4*b Transformation and shape-change; actin cross-linking/gelling
Karyopherin α2 −1.0a 1.0a 3.0*b Involved in transporting molecules through the pores of the nuclear
envelope: a part of the importin-β superfamily
Trans-Golgi network protein 1 4.7*a 1.1b 1.3b Trans-golgi assembly and recycling of trans-Golgi components
Chimerin 1 (Chimaerin) 2.9*a 1.4b −6.3*c Regulation of Rac, a subfamily of the Rho family GTPases involved in
cell organization and regulation
Chimerin 2 1.6a −1.4a −4.9*c Induces translocation of the protein from the cytosol to the Golgi
apparatus
Heat-shock 27 kDa protein family, member 3 1.4a −1.1a −3.5*b Hsp27 functions as a molecular chaperone and is involved in the
regulation of cell growth and differentiation
ADP-ribosylation factor guanine-nucleotide-
exchange factor 2 (brefeldin A-inhibited)
1.4a 1.0a −1.9*b Intracellular vesicular trafficking
Dynactin 4 1.1a 1.1a −2.3*b Aids in bidirectional intracellular organelle transport by binding to
dynein and kinesin II and linking them to the organelles to be
transported
GRB2-associated binding protein 2 1.6a 1.5a −2.6*b Principal activator of phosphatidylinositol 3-kinase involved in
cellular growth, proliferation, motility and intracellular trafficking
Vesicle-associated membrane protein 8 −1.2 a 1.2 a 2.3*b Synaptobrevins/VAMPs, syntaxins and the 25-kDa synaptosomal-
associated proteins (SNAP25) are components involved in the
docking and/or fusion of synaptic vesicles with the presynaptic
membranes
Growth, cell cycling and extracellular matrix formation
Connective tissue growth factor −3.1*a −1.2b 4.3*c Cellular matrix induction
Collagen type XXVII −2.9*a −1.2b 3.8*c In the ‘fibrillar’ class of collagens
Prolyl 4-hydroxylase α subunit −3.1*a −3.1*a 3.4*b Catalyses the formation of 4-hydroxyproline
Cyclin D2 −1.2 a −1.1 a 2.5*b Regulation of transcription and mRNA processing
Cyclin-dependent kinase inhibitor 1C, p57 −1.2 a 1.4 a 2.7*b A negative regulator of cell proliferation
Septin-like protein −1.1 a 1.2 a 1.9*b Apparent cell division cycle regulatory protein
Similar to methionyl-tRNA synthetase 3.9*a −1.7 −14.7 Apparent relationship with protein translation
p21 (CDKN1A)-activated kinase 2 1.0a −1.2a −2.3*b Kinase in the CDK important for cell cycling
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Table 3 Continued
PQQ treatment group (fold change relative to PQQ+)
Gene PQQ− PQQ+/− PQQ−/+ Associated functions
Cyclin A2 1.3a 1.5a −3.7*b Cyclins function as regulators of CDKs; CDKs are involved in the
regulation of transcription and mRNA processing
p21 (CDKN1A)-activated kinase 3 2.1*a −1.2b −8.0*c Tightly controlled by p53; important for cell cycling and G1-phase
arrest in response to a variety of stress stimuli
Prominin 1.3 a −9.0*b −29.8*c Localizes to cellular protrusions in haemopoietic and neuronal stem
cells
Integrin α E1 1.1 a 1.0a 2.4*b One of many integrin receptors that mediate attachment between a
cell and the tissues
Lamin B receptor 2.3*a −1.8*b −6.5*c Aids in anchoring the lamina and heterochromatin to cellular
membranes
Chondroadherin 1.3 a −1.9*b −5.1*c Binds cells via the integrin α-family of receptors and controls cell
spreading
Chondroitin sulfate proteoglycan 3 1.3 a −1.6a −2.1*a,b Cell matrix component
In addition, similar changes in patterns were observed for genes
associated with cellular transport, assembly, and cycling, as well
as extracellular matrix formation (Table 3), and mitochondrial-
related metabolic events and oxidant sensing (Table 4). Table 4
also lists genes that are responsive to changes in PQQ status
that are important for lipid-related energy and phospholipid
metabolism. These changes complement those observed for genes
important for transport, cellular assembly and cell signalling
(Tables 2 and 3). In addition, for the approx. 900 total genes
in the array that were significantly influenced by either PQQ
deficiency or administration, over 10% could be identified in
the MitoCarta mouse inventory. The MitoCarta mouse inventory
is a collection of 1098 nuclear and mtDNA genes (approx.
4% of the genes in the mammalian genome) that have been
judged to be essential to mitochondriogenesis (http://www.
broad.mit.edu/pubs/MitoCarta/mouse.mitocarta.html).
To verify the various categories that are presented in Tables 2–
4, an IPA tool was run using results from all the four ASD groups
(PQQ+, PQQ−, PQQ+/− and PQQ−/+). In keeping with the
categories and partial list of genes presented in Tables 2–4, IPA
resulted in similar categories that included canonical relationships
important for cellular growth and proliferation, apoptosis, cell
cycling and organization, cell–cell communication and cellular
defence (Figure 1A). More direct functional or specific categories
included a number of specific cell signalling pathways (e.g. G-
protein-coupled receptor cycling, AMPK (AMP-activated protein
kinase) signalling, IGF (insulin growth factor)-1 and insulin
receptor signalling), in addition to the genes related to steroid
synthesis, energy regulation, sphingosine metabolism, cellular
differentiation, and glycine, serine and threonine metabolism
(Figure 1B).
qRT-PCR analysis for selected array genes
Overall, an excellent correspondence was observed for the genes
chosen for microarray and the qRT-PCR data comparisons
(Figure 2). Likewise, changes in c-fos and NPY (Figure 3A)
were responsive to the changes in PQQ status, in keeping
with what may be inferred from the IPA for functional and
canonical clusters. In Figure 3(B), the relationships between
plasma PQQ levels and the fold changes for citrate synthase,
succinic acid dehydrogenase and cytochrome oxidase taken from
the microarray data (see Supplementary Figures S1 and S2)
and changes for the mtDNA/nuclearDNA (see also Table 1) are
shown. These results are in keeping with previous experiments
that have used both morphological analysis, and estimates of the
mtDNA/nuclear DNA ratio or cytochrome oxidase activity, as
indices of the qRT-PCR mitochondrial levels [1–4]. As additional
validation, Tfam and PGC-1α transcripts were examined in a
separate experiment (Figure 3C). Tfam encodes a transcription
factor that is an important activator of mitochondrial transcription.
PGC-1α is a transcriptional co-activator that regulates the genes
involved in energy metabolism. Both PGC-1α and Tfam were
influenced by changes in dietary PQQ status in a manner
consistent with the gene array data presented.
Plasma lipids
Figure 4 shows the levels of triacylglycerols and sphingosine and
the relative composition of fatty acid classes contained in each
group of rats (e.g. the percentage of saturated, mono-unsaturated
and polyunsaturated fatty acids). On the basis of the results from
the gene array assessment, it was predicted that triacylglycerols
levels would be elevated and sphingosine levels decreased in
response to PQQ dietary deficiency.
DISCUSSION
A wide range of functions has been attributed to PQQ (e.g.
improved growth, immune responsiveness and reproductive
performance). We have emphasized previously the role of PQQ
in mitochondrial function and biogenesis [1–4,20,21]; however,
the biochemical and cellular mechanisms responsible for such
effects remain obscure. Accordingly, in order to better understand
the effects of PQQ and its mechanism of action, we performed
expression microarray analysis on rats subject to differing PQQ
exposure protocols. An ASD was chosen because it could be
formulated to be nutritionally complete with all known essential
nutrients, yet free of PQQ [1–4]. It was noteworthy that merely
supplementing the ASD with micromolar amounts of PQQ
improves the global expression of numerous genes and supports
growth and reproduction similar to mice or rats fed LC diets [1–4].
In the present study we terminated the experiments at a time
when rats are sexually mature. We have observed previously
in mice that, although differences in body weight may occur
at weaning, differences in body weight (PQQ− compared with
PQQ+) are not apparent by 6–8 weeks post-weaning [4]. Thus
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Table 4 Mitochondrial, secondary metabolism and lipid-related genes influenced by changes in PQQ status
An asterisk (*) indicates a significant increase or decrease in gene expression relative to values for the corresponding control group. The analysis was performed by means of SAM analysis using
the Integromics Biomarker Discovery microarray data analysis software. Values within each row labelled with differing superscript letters indicate a difference between the groups of P < 0.05 using
a Dunnett’s test. HO, haem oxygenase; IL, interleukin.
PQQ treatment group (fold change relative to PQQ+)
Gene PQQ− PQQ+/− PQQ−/+ Associated functions
Mitochondrial and metabolism-related
Mitochondrial tumour suppressor gene 1 1.7*a 1.3a −1.7*b Mitochondrial-related apoptosis
STAT3 −1.4a 1.1a 7.0*b Interacts with IL-6; required for optimal mitochondrial function
ATP synthase, H+ transporting, mitochondrial F1
complex, γ polypeptide 1
−1.4a −1.1a 2.0*b Subunit of mitochondrial ATP synthase
ATP synthase, H+ transporting, mitochondrial F1
complex, O subunit
−1.3a 1.2a,b 1.8b* Subunit of mitochondrial ATP synthase
ATP synthase, H+ transporting, mitochondrial F1
complex, β polypeptide
1.0a −1.2a 2.5*b Subunit of mitochondrial ATP synthase
ATP synthase, H+ transporting, mitochondrial Fo
complex, subunit c, isoform 1 (5 other subunits
detected)
−1.1a 1.2a 2.3*b Subunit of mitochondrial ATP synthase
ATP synthase, H+ transporting, mitochondrial F0
complex, subunit c (subunit 9)
1.0 a 1.1a 2.3*b Subunit of mitochondrial ATP synthase
Cytochrome c oxidase subunit 4A −1.1a 1.2a 2.6*b Subunit of cytochrome c oxidase
Cytochrome c oxidase subunit VIIb −1.1a −1.1a 2.3*b Subunit of cytochrome c oxidase
HO-1 −1.7 *a −1.1a 1.9*b HO-1 is a protective antioxidant enzyme that prevents apoptosis;
inducible
HO-2 1.1a −1.1 a −1.2a Constitutive HO involved in haem catabolism used a control for HO-1
and HO-3
HO-3 −3.2*a −1.4b 22.9*c HO-3 is not catalytically active, but is thought to function as an
oxygen sensor
Hypoxia-inducible factor 1 1.0a −1.2 a −2.3*b Functions as an oxygen sensor
Phosphoserine aminotransferase 1 −6.7*a −1.0a 3.4*b Formation of phosphoserine from 3-phosphohydroxypyruvate
Glycerol kinase −2.5*a 1.0b 2.3*c Triacylglycerol formation
Succinyl-CoA ligase (ATP-forming), β chain −1.4a 1.0a 2.3*b Energy production and conversion
Glucokinase regulatory protein −1.7a 1.3b 4.7*c Glucokinase/glucose regulation
Glucokinase −1.9*a −2.9*b 2.1*c Glucose regulation
Fructose-2,6-biphosphatase 4 −1.9*a 1.6b 3.2*c Important for glycolysis and gluconeogenesis
Glutamate oxaloacetate transaminase 2 1.3a 1.6a 1.3a Amino acid metabolism
D-site albumin promoter-binding protein 4.5*a −2.8*b −5.7*c A member of the proline and acidic amino acid-rich basic leucine
zipper transcription factor family; binds to an upstream promoter
in the insulin gene
Glycogen synthase 2 1.7a −1.1b −2.6*c Regulation of glycogen synthesis
Pyruvate dehydrogenase phosphatase isoenzyme 1 1.0a −1.1a −2.7*b Energy production and conversion
Ornithine decarboxylase 1.4a 1.0a −2.3*b Urea cycle regulation
Serine dehydratase 5.5*a −1.4b −3.7*c Converts serine into pyruvate; threonine into propionyl-CoA
Secondary metabolism-related
Thioredoxin 2 −1.1a 1.1a 2.2*b Contributes to antioxidant activity by facilitating the reduction of
proteins by cysteine thiol–disulfide exchange
Aryl hydrocarbon receptor nuclear translocator −8.7*a −1.1b 9.6*b Induction of enzymes important to xenobiotic metabolism; forms a
complex with ligand-bound aryl hydrocarbon receptors required
for receptor function
Cytochrome P4508B1 hydrolase −2.8*a 1.2b 2.5*b Phase 1 xenobiotic metabolism
Cytochrome P4504A3 hydrolase −1.4a 2.1*b 3.6*b Phase 1 xenobiotic metabolism
Cytochrome P4507A1 hydrolase −2.1*a −3.0*b −3.0*b Phase 1 xenobiotic metabolism
Cysteine–sulfinate decarboxylase −4.5*a −1.0b 1.0b Hypotaurine metabolism
Glutathione transferase, mu 5 −1.2a −1.2a 2.4*b Phase II reaction functions
Lipid and phospholipid-related
Fatty acid elongase 2 −1.2a 2.5*b 12.5*c Fatty acid chain elongation
Fatty acid desaturase −2.0*a −1.2b 1.9*c Formation of unsaturated acyl chains in fatty acids
Carnitine-O-octanoyl transferase 1 −2.0*a 1.6b 1.9*b Mitochondrial transport fatty acid transport enzyme
Adiponectin receptor 2 −1.4a 1.1a 2.8*b Receptor for adiponectin binding; levels of adiponectin are inversely
correlated with body fat percentage in adults
Choline kinase −2.1*a 1.3*b 1.6b Participates in glycine, serine and threonine and glycerophospholipid
metabolism
Mevalonate pyrophosphate decarboxylase −1.9*a −1.1a 2.0*b Enzyme in the mevalonate pathway
HMG-CoA lyase −1.4a 1.0a 2.4*b Cholesterol biosynthesis
Farnesyl diphosphate synthase −1.4a 1.7b 2.0*b Conversion of geranyl diphosphate and isopentenyl diphosphate into
farnesyl diphosphate
2,3-Oxidosqualene:lanosterol cyclase −1.4a −2.1*a 1.4b Cholesterol synthesis
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Table 4 Continued
PQQ treatment group (fold change relative to PQQ+)
Gene PQQ− PQQ+/− PQQ−/+ Associated functions
Isopentenyl-diphosphate  isomerase −1.9*a −1.6a 1.8*b Steroid synthesis regulation
2,3-Oxidosqualene:lanosterol cyclase −1.7*a −1.4a 1.4a Steroid synthesis
Cytochrome P4508B1, sterol 12α hydrolase −2.7*a 1.2b 3.0*c Steroid synthesis
Lipocalcin 2 1.4a −1.6b 5.4c Transport small hydrophobic molecules such as steroids, bilins,
retinoids and lipids
Leptin receptor 2.0*a 1.3a −2.0*b Regulates adipose-tissue mass through hypothalamic effects on
satiety and energy expenditure
Sphingomyelin phosphodiesterase 2.0*a 1.0a,b −1.4b Sphingomyelin regulation; sphingomyelin is converted into
phosphocholine and ceramide
Ng22 protein 1.8*a −1.4b −2.1*b Choline transporter-like protein 4, phospholipid metabolism
CDP-diacylglycerol synthase (phosphatidate
cytidylyltransferase) 1
1.3a 1.3a −1.8*b A CTP-diacylglycerol or diacylglycerol synthetase that participates in
glycerophospholipid metabolism and phosphatidylinositol
signaling systems
Sphingolipid G-protein-coupled-receptor 5 1.5a −2.9*b −3.3*b Lipid signaling molecule that binds sphingosine 1-phosphate
Lysophospholipase 1.9*a 1.4a 1.3b Glycerophospholipid metabolism; converts
2-lysophosphatidylcholine into glycerophosphocholine
Monoacylglycerol lipase 1.0a −1.4a 3.6*b Functions together with hormone-sensitive lipase to hydrolyse
intracellular triacylglycerols
Fatty acid CoA ligase, long chain 5 1.3a 2.5*b 4.0*c Conversion of long-chain fatty acids into acyl-CoA esters
Stearoyl-CoA desaturase 2 2.1*a 4.0*b −1.2c A 9-fatty acid desaturase
Phosphatidylinositol-binding clathrin assembly
protein
1.0a −1.2a 1.9*b Clathin assembly and phospholipid metabolism
Figure 1 Network-assisted transcription profiling
PQQ-influenced genes belong to multiple activity categories. The −log of the P-values relative to the PQQ+ group are indicated, with P < 0.05 denoted by the vertical grey line. Dietary groups
correspond to: PQQ-deficient (PQQ−), black bars; short-term PQQ-deficient group (PQQ+/−), grey bars; and PQQ-repleted (PQQ−/+), white bars. (A) Canonical clusters and relationships and
(B) potential pathways and processes affected by PQQ. NS (not significant) indicates P > 0.4.
c© The Authors Journal compilation c© 2010 Biochemical Society© 2010 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
524 E. Tchaparian and others
Figure 2 qRT-PCR validation of selected genes
Expression profiles were obtained for carnitine-O-octanoyltransferase, HMG-CoA lyase, CYP4a3, CYP7a1, glucokinase, lipocalin 2, monoacylglycerol lipase, Raf1, and STAT3 and closely match
the profiles observed in the microarray analysis (Tables 1–4). Values represent fold changes in expression relative to a corresponding control group. Ratios: Control, PQQ+/PQQ+ (=1.0), PQQ
deficient, PQQ−/PQQ+ (white bars); PQQ partially depleted PQQ(+/−)/PQQ+ (black bars); PQQ-repleted PQQ(−/+)/PQQ− (grey bars).
Figure 3 NPY, c-fos, mtDNA/nuclear DNA ratio, and relative changes in succinic acid dehydrogenase, citrate synthetase, cytochrome oxidase-related
transcripts, PGC-1α and Tfam in response to dietary PQQ status
(A) Changes in NPY and c-fos levels in response to changes in PQQ exposure. Values represent fold changes in expression relative to a corresponding control group. Ratios: Control, PQQ+/PQQ+
(=1.0), PQQ deficient, PQQ−/PQQ+ (white bars); PQQ partially depleted PQQ(+/−)/PQQ+ (black bars); PQQ-repleted PQQ(−/+)/PQQ− (grey bars). The superscript letter values indicate that
there was a difference between groups (P < 0.05 using a Dunnett’s post-test). (B) Plasma PQQ and the relative content or fold changes for liver mtDNA and succinic acid dehydrogenase (SDH),
citrate synthetase (CS) and cytochrome oxidase-related transcripts (Cyt OX). Values for r2 (plasma PQQ compared with relative fold-changes) ranged from approx. 0.72 to 70.95. (C) Relationship of
Tfam to PGC-1α (relative changes in transcript levels) in PQQ− rats () or PQQ+ rats (). Changes in PGC-1α and Tfam transcripts levels (estimated by qRT-PCR) and the mtDNA/nuclear DNA
ratio are expressed as a percentage of control values (insert). *P < 0.05; **P < 0.2.
the inability to gain weight or growth was in part excluded as
a variable. Regarding plasma PQQ levels, the values for ASD-
fed rats reflected the dietary exposure to PQQ with the caveat
that the lower values for plasma PQQ for rats fed the LC diets
may reflect variable intake, PQQ adduct formation because of the
complexity of the LC diet or decreased bioavailability of PQQ as
a result of LC processing and preparation. Another caveat is that
the GDH assay used for PQQ measurements only measures ‘free’
PQQ and not PQQ bound to protein or in the form of IPQ, the
principal PQQ–amino acid adduct. The extent to which IPQ may
contribute to the total functional body pool of PQQ remains to be
fully assessed.
When defined in functional categories or clusters, genes that
were influenced or changed significantly in response to PQQ
deficiency were rapidly reversed or normalized upon repletion
with PQQ. This was particularly apparent for genes associated
with cell signalling, stress and apoptosis. Components of the
JAK/STAT signalling pathway seemed to be a major target, which
is important for the regulation of cellular responses to a large
number of cytokines and growth factors. The apparent changes
observed in c-fos (up-regulation) and NPY (down-regulation)
mRNA levels are consistent with alterations in JAK/STAT-related
pathways [36–39].
The responsiveness of BAX and STAT3 to changes in PQQ
status was also viewed as important. STAT3 is activated in
response to various cytokines and growth factors and is involved
in the control of respiration by mitochondria [46]. STAT3-null
mouse embryos do not develop beyond embryonic day 7 [47].
STATs in combination with JAKs are cell signalling alternatives
to the second messenger systems [46]. STAT3 is also present in
mitochondria and when down-regulated can affect the activities
of complexes I and II in the electron transport chain [46].
The BAX gene was the first identified as the pro-apoptotic
member of the Bcl-2 protein family [48,49]. The majority of
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Figure 4 Plasma sphingomyelin and triacylglycerol levels
PQQ exposure had a significant effect on plasma sphingomyelin and triacylglycerol levels. The
superscript letters indicate that there was a difference between groups (P < 0.05 using a Dunnett’s
post-test). The major fatty acid classes contained in the sphingomyelin and triacylglycerol
fractions are: polyunsaturated fatty acids (black), mono-unsaturated fatty acids (grey) and
saturated fatty acids (white bars). Results are means+S.E.M (n = 6).
Figure 5 Proposed pathways regulated by dietary PQQ
Several major signalling pathways are modulated by changes in PQQ dietary status. Given the
broad range of responses, PQQ is proposed to bind to a cell surface receptor that triggers
responses from one or more transducers. The JAK/STAT3 pathway is highlighted, because
STAT3 is up-regulated and influences the expression of a variety of genes that play key roles in
cellular processes such as cell proliferation, differentiation and apoptosis. The link to AMPK is
based in part on the down-regulation of NPY. Cross-talk between Raf-1 and STAT3 is inferred
(broken arrow), because of the known inter-relationships between MAPK/ERK signalling and
STAT3, and the up-regulation of c-Fos, Raf-1 and Ras following exposure to either dietary or
pharmacological levels of PQQ. The MAPK p58 family (e.g., MAPKKK12 and MAPK14) is also
involved. The combination of the two cell signalling pathways can lead to the up-regulation or
activation of PGC-1α, PPARα (peroxisome-proliferator-activated receptor α) and CREB as end
products.
BAX is found in the cytosol, but, upon initiation of apoptotic
signalling, BAX inserts into the outer mitochondrial membrane
and aids in opening of the mitochondrial voltage-dependent anion
channels and plays a role in mitochondrial outer membrane
permeabilization. Such observations are consistent with the
relative changes associated with mitochondriogenesis (e.g. a
lower ratio of mtDNA to nuclear DNA, lower levels of liver PGC-
1α and Tfam mRNA, and the disproportionately high number of
mitochondrial-related genes that respond significantly to changes
in PQQ status). The results are also consistent with previous
observations showing that cytochrome oxidase and succinic acid
dehydrogenase enzymatic activity is relatively lower in PQQ-
deprived rats, a good indirect measure of mitochondrial numbers
[1,20]. Moreover, the elevation in triacylglycerol and decrease in
sphingosine levels provide additional validation and a functional
consequence in the altering transcriptional networks by PQQ.
As a summary, the changes discussed above are highlighted
in Figure 5, which integrates how varying PQQ exposure alters
cell signalling. JAK/STAT and MAPK-related pathways seem
particularly influenced by PQQ. As examples, MAPK14, a kinase
in the p38 kinase family, is required for BAX translocation
to mitochondria, cytochrome c release and apoptosis [49,50].
MAPK14 was up-regulated by PQQ deprivation (Table 2).
In contrast, MAPKKK (MAPK kinase kinase) 12 was up-
regulated by PQQ repletion (Table 2). The up-regulation
of MAPKKK12 can be linked to CREB activation and
increased mitochondriogenesis [50], in keeping with our previous
observations that PQQ can influence CREB phosphorylation and
PGC-1α and Tfam mRNA expression [20], as well as from
the results presented in Figure 3; these results also indicate
that JAK/STAT signalling is activated (e.g. based in part on
changes in STAT3, NPY and BAX). PQQ seems to modulate
cell signalling pathways important for both apoptosis [49–51]
and mitochondrial assembly [52]. As a final point, it is also of
importance that among the antioxidant enzymes influenced by
PQQ, significant changes in thioredoxin-related transcripts were
observed (Table 4). Thioredoxin not only plays a role in anti-
oxidative defence, but also catalyses the inter- and intra-molecular
disulfide bonds in proteins [53]. An important activity is S-
glutathionylation and deglutathionylation to protect thiol groups
in proteins from oxidation, which is particularly important for the
regulation of transcription factor activity [53].
Taken together, the observations suggest that a closer
examination of PQQ and its related derivatives is justified, given
that compromised mitochondrial function is easily linked to
diseases and metabolic disorders [54]. For example, in contrast
with other compounds that provoke changes in mitochondrial
number and function (quercetin, hydroxytyrosol and resveratrol
[36]), the effects of PQQ occur at low levels of intake (at nano-
to micro-molar levels in diets in contrast with near millimolar
levels) and are dynamic, i.e. appear to be modulated by not only
the amount but also the duration of PQQ exposure.
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Figure S1 Box plot analysis of log2-transformed expression values of Codelink® data of PQQ samples
A total of 9482 probe sets were used. The box is drawn from the 25th and 75th percentiles in the distribution of intensities. The median, or 50th percentile, is drawn inside the box. The lines extending
from the box describe the ranges for the data. The log2-transformed intensities were quantile-normalized using the IBD Integromics software package. The method is employed to remove systematic
effects and brings the data from different microarrays on to a common scale for comparison. The ends of the vertical lines indicate the minimum and the maximum values, and the points outside the
ends of the vertical line are outliers.
1 Correspondence may be addressed to either of these authors (email eskouhie@amgen.com or rbrucker@ucdavis.edu).
The raw microarray data from the present study are available from the NCBI (National Center for Biotechnology Information) GEO (Gene Expression
Omnibus) database (http://www.ncbi.nlm.nih.gov/geo) under accession number GSE17811, and are also available with the Supplementary data for this
article at http://www.BiochemJ.org/bj/429/bj4290515add.htm.
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Figure S2 Overview of global gene expression of different PQQ treatments as provided by the complete linkage clustering algorithm
The row dendrogram shows the similarity between rows and shows nodes to which each gene belongs to as a result of the clustering. The vertical axes represent different treatment groups. On the basis
of their gene expression pattern, clustering analysis clearly separated the different groups (PQQ−, middle dendrogram; PQQ+/−; left-hand dendrogram; and PQQ−/+, right-hand dendrogram) as
displaying distinct expression profiles corresponding essentially to repressed or activated genes relative to the experimental control. Up-regulated genes are shown in red and down-regulated genes
are shown in green. The fold change cut-off was 1.5 (PQQ−/+), q-value<5
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